Robert Carlson is a principal at Biodesic, a biological engineering, consulting, and design firm in Seattle. He earned a doctorate in physics from Princeton University and is interested in the future role of biology as a human technology. He is the author of Biology Is Technology: The Promise, Peril, and Inevitability of Engineering Life, to be published in late 2009.
The majority of biotech products that have reached the market are the result of just a handful of genetic modifications and insertions. The commercial significance of the biotech sector will grow as its ability to engineer new biological systems expands.
Send an e-mail to let us know how we can make our site better.
New research from the McKinsey Global Institute suggests that the forces fueling growth in financial markets have changed.
Zhou Xiaochuan, China's central bank governor, calls for a new world currency, in a March 2009 speech.